Skip to main content

Peer Review reports

From: Crisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune system

Original Submission
9 Jun 2024 Submitted Original manuscript
2 Jul 2024 Author responded Author comments - Hwa-Young Youn
27 Jul 2024 Author responded Author comments - Hwa-Young Youn
Resubmission - Version 2
2 Jul 2024 Submitted Manuscript version 2
26 Aug 2024 Reviewed Reviewer Report
27 Aug 2024 Reviewed Reviewer Report
11 Nov 2024 Author responded Author comments - Hwa-Young Youn
Resubmission - Version 3
11 Nov 2024 Submitted Manuscript version 3
19 Nov 2024 Author responded Author comments - Hwa-Young Youn
Resubmission - Version 4
19 Nov 2024 Submitted Manuscript version 4
13 Dec 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
17 Dec 2024 Editorially accepted
3 Jan 2025 Article published 10.1186/s12868-024-00920-w

You can find further information about peer review here.

Back to article page